Researchers at The University of Texas at Austin College of Pharmacy stand on the cusp of discovery. Read about some of the new initiatives emerging from their research labs below.
Parkinson Gene Link May Aid Battle Against Disease
Dr. Somshuvra Mukhopadhyay, assistant professor of pharmacology and toxicology, led the research team that focused on the gene SLC30A10 and its role as a "door opener" in helping to remove elevated levels of manganese from cells. The study was published in the Oct. 15 issue of The Journal of Neuroscience.
Read more about Dr. Mukhopadhyay's research at the college.
Reveles Traces Rate of Hospital Infections
Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.
Read more about Dr. Reveles' findings.
$3.3M Grant Award
College researchers are among a team working to develop medication to treat alcoholism and drug addiction that could target individual genes or brain signaling systems.
Read more about addiction research at the college.
Stopping Cancer in its Tracks
Cancer researcher Kevin Dalby says he thinks scientists are on track to find a cure for cancer one day.
Read more about cancer research at the college.
UT Advance Opens
The College of Pharmacy has opened a laboratory that fills a critical gap in the process of developing new drugs and biotechnology products.
Read more about UT Advance.
College to Offer Ph.D. in
On average, 24 years pass before a major scientific discovery makes its way from the research laboratory to patient care settings. The College of Pharmacy is working to speed up this process by joining forces with other University of Texas institutions to establish a new doctoral program in translational science.
Read more about the translational science program.
Researchers Offer Promise Through Enhanced Drug Delivery
Working in the pharmaceutical industry, Dr. Bill Williams became increasingly frustrated as he saw new drugs being developed to treat life-threatening diseases only to see them discontinued because the medicine wasn't getting to the disease site. He decided to change jobs and so something about the problem.
Read more about Dr. Williams' research.
Grant Supports Research to Fight Lung Disease
Dr. Hugh Smyth, assistant professor of pharmaceutics, has been awarded a $2,180,539 grant from the National Institute of Health's National Heart, Lung and Blood Institute for his investigation, "Multifunctional nanoparticles: Nanoknives and nanopullies for enhance drug delivery to the lung." Work in his research lab will address obstacles for combating many lung diseases by focusing on treatments for cystic fibrosis.
Read more about Hugh Smyth's research.
DiGiovanni Receives $2.5 Million Grant
Dr. John DiGiovanni, the Coulter R. Sublett Chair in Pharmacy, is one of two researchers at The University of Texas at Austin to receive a $2.5 million grant to establish a training program for a new generation of cancer researchers. The award, which comes from the Cancer Prevention and Research Institute of Texas (CPRIT), was awarded to Dr. Jonathan Sessler, professor of chemistry, as the principal investigator and to DiGiovanni as the co-principal investigator. It is the largest award among $3.3 million in grants to UT Austin researchers announced by CPRIT in July 2010.
Alcohol/brain chemistry interaction study
Dr. Rueben Gonzales, professor of pharmacology and toxicology, has devoted his professional life to investigating the chemical changes in the brain that underlie alcohol addiction. His is a highly productive research lab and recently he was awarded for his years of work when he was named recipient of a $2.8 million MERIT grant, one of the most prestigious funding awards from the National Institutes of Health.
Read more about Rueben Gonzales' research.
Effects of environmental toxicants on male fertility
Dr. John Richburg, associate professor of pharmacology and toxicology, is examining what role a class of compounds, called phthalates, may play in male infertility problems. His research is supported by a new $1.5 million grant from the National Institutes of Health.
Read more about John Richburg's research.
New hope for lung transplant, asthma patients
Dr. Robert O. Williams, professor of pharmaceutics, is working with a collaborative team in an effort to bring new hope to lung transplant and asthma patients. Their work is so promising that they recently received funding from the Texas Ignition Fund, a UT System program designed to speed up the commercialization of products created by UT System institutions.
Read more about Robert O. Williams' research.
Read more about Andrea Gore's research.
Breaking the antibiotic habit
Dr. Hung-Wen (Ben) Liu, professor of medicinal chemistry, works everyday in his lab to outsmart mother nature. Just four years after drug companies began mass-producing penicillin in 1943, microbes began surfacing that could resist it. In his lab, Liu and his team work to develop weapons to use against antibiotic-resistant bacteria.
Read more about Ben Liu's research.
College of Pharmacy
The University of Texas
2409 University Ave.
Austin, TX, USA
Email Address: pharmacy
Two awards were recently announced by AFPE to support UT fellows.
Read the full story about
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded a $1 million grant to Dr. Kevin Dalby, associate professor of medicinal chemistry.
Read the full story about
Dr. Carlton Erickson, the associate dean for research and graduate studies, has been selected as a distinguished pharmacy alumnus at Purdue University.
Learn more about